Nektar Therapeutics (NKTR) - Financial and Strategic SWOT Analysis Review

Date: April 19, 2016
Pages: 51
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: N4C8EF32BC6EN
Leaflet:

Download PDF Leaflet

Nektar Therapeutics (NKTR) - Financial and Strategic SWOT Analysis Review
Nektar Therapeutics (NKTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Nektar Therapeutics (Nektar) is a biopharmaceutical company. It carries out discovery and development of a pipeline of novel therapeutic drug candidates based on its PEGylation and advanced polymer conjugate technology platforms to address unmet medical needs. Nektar’s technology platformns offers a wide array of functional attributes, which optimizes and enhances the profile of wide range of molecules including many classes of drugs targeting numerous disease areas. The company’s products focuses on various therapeutic areas, including, cancer, pain, anti-infectives, anti-viral and immunology among others. Its research and development activities involve peptides, small molecule drugs, and other potential biologic drug candidates. Nektar Therapeutics is headquartered in San Francisco, California, the US.

Nektar Therapeutics Key Recent Developments

Mar 01, 2016: Nektar Therapeutics Reports Fourth Quarter and Year-End 2015 Financial Results
Nov 05, 2015: Nektar Therapeutics Reports Financial Results for the Third Quarter of 2015
Oct 08, 2015: Nektar Reports on Advancements with Pain and Oncology Clinical Pipeline at Investor and Analyst R&D Day
Aug 05, 2015: Nektar Therapeutics Reports Financial Results for the Second Quarter of 2015
Apr 30, 2015: Nektar Therapeutics Reports Financial Results for the First Quarter of 2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    Nektar Therapeutics - Key Facts
    Nektar Therapeutics - Key Employees
    Nektar Therapeutics - Key Employee Biographies
    Nektar Therapeutics - Major Products and Services
    Nektar Therapeutics - Pharmaceutical Pipeline Products Data
    Nektar Therapeutics, Pipeline Products by Therapy Area
    Nektar Therapeutics, Pipeline Products by Development Phase
    Nektar Therapeutics - Medical Equipment Pipeline Products Data
    Nektar Therapeutics Pipeline Products by Equipment Type
    Nektar Therapeutics - History
    Nektar Therapeutics - Company Statement
    Nektar Therapeutics - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries

    SECTION 2 – COMPANY ANALYSIS

    Nektar Therapeutics - Business Description
    Nektar Therapeutics - Corporate Strategy
    Nektar Therapeutics - SWOT Analysis
    SWOT Analysis - Overview
    Nektar Therapeutics - Strengths
    Strength - Research and Development
    Strength - Proprietary Technology
    Strength - Strategic Partnerships
    Strength - Liquidity Position
    Nektar Therapeutics - Weaknesses
    Weakness - Operating Loss Carryforward
    Nektar Therapeutics - Opportunities
    Opportunity - Product Pipeline
    Opportunity - Demographic Trends
    Opportunity - Product Approval and Launches
    Nektar Therapeutics - Threats
    Threat - Uncertain R&D Outcomes
    Threat - Government Regulations
    Threat - Competitive Environment
    Nektar Therapeutics - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Nektar Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Nektar Therapeutics, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Nektar Therapeutics, Recent Deals Summary

    SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

    Mar 01, 2016: Nektar Therapeutics Reports Fourth Quarter and Year-End 2015 Financial Results
    Nov 05, 2015: Nektar Therapeutics Reports Financial Results for the Third Quarter of 2015
    Oct 08, 2015: Nektar Reports on Advancements with Pain and Oncology Clinical Pipeline at Investor and Analyst R&D Day
    Aug 05, 2015: Nektar Therapeutics Reports Financial Results for the Second Quarter of 2015
    Apr 30, 2015: Nektar Therapeutics Reports Financial Results for the First Quarter of 2015
    Feb 26, 2015: Nektar Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results

    SECTION 6 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Nektar Therapeutics, Key Facts
    Nektar Therapeutics, Key Employees
    Nektar Therapeutics, Key Employee Biographies
    Nektar Therapeutics, Major Products and Services
    Nektar Therapeutics, Number of Pipeline Products by Therapy Area
    Nektar Therapeutics, Number of Pipeline Products by Development Stage
    Nektar Therapeutics, Pipeline Products By Therapy Area and Development Phase
    Nektar Therapeutics Number of Pipeline Products by Equipment Type
    Nektar Therapeutics Pipeline Products by Equipment Type
    Nektar Therapeutics, History
    Nektar Therapeutics, Other Locations
    Nektar Therapeutics, Subsidiaries
    Nektar Therapeutics, Key Competitors
    Nektar Therapeutics, Ratios based on current share price
    Nektar Therapeutics, Annual Ratios
    Nektar Therapeutics, Interim Ratios
    Nektar Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Nektar Therapeutics, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Nektar Therapeutics, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Nektar Therapeutics, Pipeline Products by Therapy Area
    Nektar Therapeutics, Pipeline Products by Development Phase
    Nektar Therapeutics Pipeline Products by Equipment Type
    Nektar Therapeutics, Performance Chart (2011 - 2015)
    Nektar Therapeutics, Ratio Charts
    Nektar Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Nektar Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
    Skip to top


    Ask Your Question

    Nektar Therapeutics (NKTR) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: